Patently Innovative

How Pharmaceutical Firms Use Emerging Patent Law to Extend Monopolies on Blockbuster Drugs

By

  • R A Bouchard, Intellectual Property Lawyer and Scholar, Canada

Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products.
View full description

Audience

Patent attorneys and intellectual property personnel at pharmaceutical and biotechnology companies

 

Book information

  • Published: January 2012
  • Imprint: Woodhead Publishing
  • ISBN: 978-1-907568-12-1


Table of Contents

Drug approval, drug patenting, pharmaceutical linkage, and public health policy; Empirical analysis of drug approval; Empirical analysis of pharmaceutical innovation and drug approval-drug patenting linkage; Empirical analysis of drug patenting in multiple high-value cohorts; Implications of empirical data: Are pharmaceutical linkage regulations a success? Future directions: Testable hypotheses and evolution toward global pharmaceutical linkage.